miR-106b-5p and miR-17-5p could predict recurrence and progression in breast ductal carcinoma in situ based on the transforming growth factor-beta pathway

ConclusionmiR-106b-5p and miR-17-5p might have a role in breast cancer recurrence and progression by suppressing TGF- β activity, leading to early breast cancer carcinogenesis.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research